Skip to main content
. 2025 May 23;17(11):1761. doi: 10.3390/nu17111761
AHR Aryl hydrocarbon receptor;
AKT1 AKT serine/threonine kinase 1;
ANGPT1 Angiopoietin 1;
CCR2 C-C motif chemokine receptor 2;
CCR5 C-C motif chemokine receptor 5;
CD274 CD274 molecule;
CD68 CD68 molecule;
DAMP Damage-Associated Molecular Pattern;
HAVCR2 Hepatitis A virus cellular receptor 2;
HDAC7 Histone deacetylase 7;
HEY1 Hes-related family bHLH transcription factor with YRPW motif 1;
HLA-DQB2 Major histocompatibility complex, class II, DQ beta 2;
IL11RA Interleukin 11 receptor subunit alpha;
IL15 Interleukin 15;
IRB Institutional Review Board;
IRF8 Interferon regulatory factor 8;
KIR2DL3/4 Killer cell immunoglobulin-like receptor, two Ig domains and long cytoplasmic tail ¾;
KLRC1 Killer cell lectin-like receptor C1;
LAG3 Lymphocyte activation gene-3;
LILRA4 Leukocyte immunoglobulin-like receptor A4;
LPS Lipopolysaccharide;
MSM Methylsulfonylmethane;
NCR3 Natural cytotoxicity triggering receptor 3;
NT5E Interferon regulatory factor 8 5′-nucleotidase ecto;
OSM Oncostatin M;
PAMP Pathogen-Associated Molecular Pattern;
PSMA1 Proteasome 20S subunit alpha 1;
PSMB10 Proteasome 20S subunit beta 10;
RORC RAR-related orphan receptor C;
SESN2 Sestrin 2;
SIGLEC6 Sialic acid-binding Ig-like lectin 6;
SOCS3 Suppressor of cytokine signaling 3;
XCL1/2 Lymphotactin;
ZFP36L2 ZFP36 ring finger protein like 2